TCA 35% versus phenol 88% in treatment of alopecia areata
Not Applicable
- Conditions
- Skin and Connective Tissue DiseasesAlopecia areata
- Registration Number
- PACTR201804003334544
- Lead Sponsor
- no sponsor
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Subjects with multifocal patchy AA of the scalp (> 2 patches).
Both genders.
Age group > 4 years old.
Exclusion Criteria
Any subject with any variant of AA other than the multifocal patchy variant.
Any subject with end-stage cicatrized AA.
Any subject who is currently experiencing significant spontaneous regrowth of terminal hair.
Any subject treated with a topical, intralesional or systemic agent likely to cause regrowth in AA within one month prior to enrollment in the study.
Any subject with a dermatological condition affecting the scalp other than AA: e.g. psoriasis, eczema.
Any subject with psychiatric illness or psychological state interfering with compliance or influencing the expectation of the patient.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of TCA 35% and phenol 88% in the treatment of alopecia areata
- Secondary Outcome Measures
Name Time Method tolerability of TCA 35% and phenol 88% in alopecia areata treatment